GARIN1B
Golgi-associated RAB2 interactor protein 1B
Also known as: FAM137A, FAM71F1, GAR1B_HUMAN, GARI-L1, NYD-SP18
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96KD3
- Gene
- GARIN1B
- Ensembl
- ENSG00000135248
- Chromosome
- 7
- Canonical length
- 344 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol
OverviewNCBI Gene
Predicted to be involved in acrosome assembly and acrosome reaction. Predicted to be located in Golgi apparatus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
344 residues, UniProt reviewed canonical sequence.
>Q96KD3|GARIN1B
1 MLSSFPHRKT WRKSKKTVKV TRSYPTFPSL NAWEEFRGLL PVDGEPNPGA GLGVEEGLLC
61 RVVHSPEFNL FLDSVVFESN FIQVKRGRNW RDVYKASNTM ALGVTSSVPC LPLPNILLMA
121 SVKWHQGQNQ TWNRPSIAPN IFLKRILPLR FVELQVCDHY QRILQLRTVT EKIYYLKLHP
181 DHPETVFHFW IRLVQILQKG LSITTKDPRI LVTHCLVPKN CSSPSGDSKL VQKKLQASQP
241 SESLIQLMTK GESEALSQIF ADLHQQNQLS FRSSRKVETN KNSSGKDSSR EDSIPCTCDL
301 RWRASFTYGE WERENPSGLQ PLSLLSTLAA STGPQLAPPI GNSILocalizationUniProt · AlphaFold · HPA
Whether an antibody against GARIN1B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 89 nTPM
Expression across tissuesHPA
Tissue
- testis: 89 nTPM
- midbrain: 0.9 nTPM
- retina: 0.9 nTPM
- basal ganglia: 0.8 nTPM
- amygdala: 0.7 nTPM
- cerebral cortex: 0.5 nTPM
Single-cell type
- late spermatids: 3,032 nCPM
- early spermatids: 1,409 nCPM
- late primary spermatocytes: 332 nCPM
- cone photoreceptor cells: 10 nCPM
- epididymal clear cells: 10 nCPM
- sertoli cells: 10 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 1.8 nTPM
- thalamus: 1.6 nTPM
- amygdala: 1.3 nTPM
- pons: 1.2 nTPM
- cerebral cortex: 1.1 nTPM
- basal ganglia: 1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.18
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GARIN1B as an antibody target. Whether an autoantibody or antibody against GARIN1B could matter depends on whether native GARIN1B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GARIN1B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GARIN1B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...